Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.16T
Market cap1.16T
Price-Earnings ratio
40.36
Price-Earnings ratio40.36
Dividend yield
0.58%
Dividend yield0.58%
Average volume
3.09M
Average volume3.09M
High today
$1,197.90
High today$1,197.90
Low today
$1,161.20
Low today$1,161.20
Open price
$1,191.30
Open price$1,191.30
Volume
652.56K
Volume652.56K
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,177.41, giving the company a market capitalization of 1.16T. It carries a P/E multiple of 40.36 and pays a dividend yield of 0.58%.

On 2026-08-07, Eli Lilly(LLY) stock traded between a low of $1,161.20 and a high of $1,197.90. Shares are currently priced at $1,177.41, which is +1.4% above the low and -1.7% below the high.

The Eli Lilly(LLY)'s current trading volume is 652.56K, compared to an average daily volume of 3.09M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

LLY News

TipRanks 1h
Eli Lilly price target raised to $1,376 from $1,370 at Truist

Truist raised the firm’s price target on Eli Lilly (LLY) to $1,376 from $1,370 and keeps a Buy rating on the shares. Eli Lilly delivered strong Q2 performance w...

Nasdaq 5h
Every S&P 500 Sector ETF Ranked by How Much It Actually Depends on Just 3 Stocks

Key Points Investors often use sector ETFs to tilt their portfolios towards a specific theme. In reality, most market-cap-weighted sector ETFs are simply bets...

Every S&P 500 Sector ETF Ranked by How Much It Actually Depends on Just 3 Stocks
Bloomberg 5h
Novo Nordisk Receives Downbeat Diagnosis From Investors - Bloomberg.com

...

Novo Nordisk Receives Downbeat Diagnosis From Investors - Bloomberg.com

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
12.9%
Sell
6.5%

More LLY News

Investor's Business Daily 19h
Twilio Earnings, Revenue Beat As Voice-Based AI Tools Gain Traction

Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test 8/03/2026 As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings...

Twilio Earnings, Revenue Beat As Voice-Based AI Tools Gain Traction
Investor's Business Daily 21h
Industrial Products Leader Leaps Past Buy Point As Earnings Roar Past Estimates

Stocks To Watch: 14 Names Test And Tease New Buy Zones 7/08/2026 A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to ke...

Industrial Products Leader Leaps Past Buy Point As Earnings Roar Past Estimates
TipRanks 1d
Eli Lilly Outperformance and Incretin Momentum Support Buy Rating with Unchanged $1,385 Price Target

Courtney Breen, an analyst from Bernstein, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,385.00. Unlock pow...

TipRanks 1d
Rumors Swirl That Eli Lilly Will Split Its Stock After Blockbuster Earnings

Rumors are swirling that Eli Lilly (LLY) will announce a stock split after the company’s blockbuster earnings report sent its shares sharply higher. LLY stock...

CNBC 1d
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Key Points Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly's results, they...

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
Seeking Alpha 1d
Amazon delivers GLP-1s for $50 per month for Medicare recipients

Amazon Pharmacy (AMZN) has joined a federal program to offer GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) to eligible Medicare enrollees...

Amazon delivers GLP-1s for $50 per month for Medicare recipients
TipRanks 1d
Michael Yee Reiterates Buy Rating and Maintains $1,425 Price Target on Strong Earnings Power and Obesity Portfolio Momentum

Analyst Michael Yee from UBS maintained a Buy rating on Eli Lilly & Co and keeping the price target at $1,425.00. Unlock powerful investing tools with TipRanks...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.